Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibodies
Biotech
New biotech Slate aims to solve migraine injection equation
Slate is etching a total of $130 million into the chalkboard, money that will go toward a monoclonal antibody licensed from DartsBio Pharmaceutical.
Gabrielle Masson
Feb 24, 2026 7:30am
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am
Sanofi signs 2nd biotech deal of the day
Dec 15, 2025 5:50pm
FDA issues plan to reduce primate testing for certain antibodies
Dec 2, 2025 11:25am
Regeneron antibodies post ph. 3 wins against cat, pollen allergy
Sep 8, 2025 9:54am
Junshi sees ph. 3 psoriasis win for IL-17 drug, preps China push
Sep 8, 2025 4:54am
